FDA has issued a warning of increased Thrombotic Event (Bleeding and Hemorrhage)! Xarelto is prescribed to prevent strokes in people with arterial fibrillation; as a treatment for deep vein thrombosis and pulmonary embolism; it was first to prevent deep thrombosis in patients undergoing hip or knee replacement surgery. Xarelto Blood Thinner is under investigation by the FDA. The FDA has received 68– adverse reports related to the patients using the blood thinner. Doctors state there is no way to reverse the effects of this dangerous drug. The complaints point out that while warfain bleeding can be reversed via the administration of vitamin K, there is no antidote to stop the bleeding that sometimes occurs with Xarelto. Patients can develop internal bleeding. Xarelto patients who experienced uncontrollable internal GI bleeding, deep vein thrombosis, pulmonary embolism, or other serious complication may be able to pursue a legal claim against the drug manufacturers. Contact Houssiere, Durant & Houssiere, LLP at (713) 626-3700 today.